Stockreport

BridgeBio Pharma Reports Fourth Quarter and Full Year 2024 Financial Results and Commercial Update [Yahoo! Finance]

BridgeBio Pharma, Inc.  (BBIO) 
Last bridgebio pharma, inc. earnings: 3/2 08:29 am Check Earnings Report
PDF - Attruby (acoramidis), the first and only near-complete TTR stabilizer (=90%) was approved by the FDA to reduce cardiovascular death and cardiovascular-related hospita [Read more]